Study on the risk signal mining related to brigatinib based on the US FDA Adverse Event Reporting System
Fu Zhonghua, Guo Zihan, Wang Mengmeng, Du Qiong, Zhai Qing
Adverse Drug Reactions Journal . 2023, (1): 34 -39 .  DOI: 10.3760/cma.j.cn114015-20220822-00771